Trinity Industries (TRN) 28.70 $TRN NYSE stocks posting

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Trinity Industries (TRN) 28.70 $TRN

NYSE stocks posting largest percentage decreases
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
HLF: 41.10 (-3.75), EMES: 44.65 (-5.95), DDD: 27.23 (-2.92), TRN: 28.70 (-4.66), UIS: 21.82 (-1.73), XRX: 11.99 (-1.15), CDE: 5.17 (-0.39)

Trinity Industries Shows Value Despite The Noise
Kurt Christensen - at Seeking Alpha - Fri Apr 24, 5:22PM CDT

TRN: 28.70 (-4.66)

Trinity Industries (TRN) Timothy R. Wallace on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Apr 24, 5:03PM CDT

TRN: 28.70 (-4.66)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 11:45AM CDT

INNL: 9.90 (+1.28), AWAY: 27.18 (-4.99), ACTG: 11.10 (+1.08), AERI: 12.87 (-22.52), DV: 30.70 (-6.87), CVTI: 33.15 (-2.44), MXWL: 6.33 (-0.85), TBI: 29.20 (+4.39), NFEC: 2.13 (-0.17), SPNC: 26.52 (-8.18), GIMO: 29.75 (+6.16), AMSC: 6.88 (-3.12), CPRX: 3.69 (-0.98), LOOK: 1.97 (+0.37), TRN: 28.70 (-4.66), IMH: 19.20 (+4.78), PGI: 10.79 (+1.29), FPP: 1.69 (+0.46), LEU: 5.22 (+0.58), EHTH: 13.50 (+2.06)

Trinity Industries (TRN) Stock Sinking Today Despite Earnings Beat
at The Street - Fri Apr 24, 11:09AM CDT
Trinity Industries (TRN) stock is tanking on Friday despite the company's better than expected first-quarter earnings results.
TRN: 28.70 (-4.66)

Ryan & Maniskas, LLP Announces Investigation of Trinity Industries Inc.
PR Newswire - Fri Apr 24, 10:28AM CDT
Ryan & Maniskas, LLP has commenced an investigation into potential securities law violations by certain officers of Trinity Industries Inc. ("Trinity" or the "Company" (NYSE: TRN).
TRN: 28.70 (-4.66)

Trinity Industries tops Street 1Q forecasts
Automated Insights - Thu Apr 23, 5:13PM CDT
DALLAS (AP) _ Trinity Industries Inc. (TRN) on Thursday reported first-quarter profit of $180.2 million.
TRN: 28.70 (-4.66)

Trinity beats by $0.17, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 3:20PM CDT

TRN: 28.70 (-4.66)

Trinity Industries, Inc. Announces First Quarter 2015 Results
Business Wire - Thu Apr 23, 3:05PM CDT
Trinity Industries, Inc. (NYSE:TRN) today announced earnings results for the first quarter ended March 31, 2015, including the following significant highlights:
TRN: 28.70 (-4.66)

Block & Leviton LLP Announces That It Has Launched An Investigation of Trinity Industries, Inc. For Possible Violations Of The Federal Securities Laws
PR Newswire - Thu Apr 23, 12:56PM CDT
Block & Leviton LLP (www.blockesq.com), a Boston-based law firm representing investors nationwide, is investigating possible securities law violations by Trinity Industries, Inc. ("Trinity" or the "Company" (NYSE: TRN). The investigation concerns whether Trinity and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and/or breached their fiduciary duties the Trinity's shareholders.
TRN: 28.70 (-4.66)

TRN INVESTOR ALERT: Investigation of Trinity Industries, Inc. Announced by The Law Offices of Howard G. Smith
Business Wire - Thu Apr 23, 9:30AM CDT
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Trinity Industries, Inc. ("Trinity" or the "Company" (NYSE: TRN) concerning the Company's and its officers' possible violations of federal securities laws. Howard G. Smith, Esq. is preparing a class action to recover damages on behalf of injured Trinity shareholders.
TRN: 28.70 (-4.66)

Weak On High Volume: Trinity Industries (TRN)
at The Street - Thu Apr 23, 9:07AM CDT
Trade-Ideas LLC identified Trinity Industries (TRN) as a weak on high relative volume candidate
TRN: 28.70 (-4.66)

Wall Street Breakfast: Where's The Value These Days?
Wall Street Breakfast - at Seeking Alpha - Thu Apr 23, 5:27AM CDT

CXO: 125.84 (-0.64), PZN: 9.25 (+0.05), OCR: 86.11 (-0.20), BTG: 1.55 (-0.03), HL: 3.04 (-0.06), AUQ: 3.43 (-0.11), SKX: 89.66 (+2.79), CNQ: 33.62 (-0.01), INTC: 32.08 (-0.27), GOOG: 565.06 (+18.06), RRC: 61.36 (-0.58), NOK: 7.76 (-0.09), UUUU: 5.30 (-0.12), PBR: 9.99 (+0.59), URRE: 1.41 (-0.05), KGC: 2.30 (-0.01), GSM: 21.17 (+0.17), DNN: 0.95 (-0.02), SLW: 19.16 (-0.19), EOG: 96.72 (-1.55), TMUS: 34.31 (-0.13), SIRI: 3.96 (+0.03), MA: 90.72 (-0.16), AEC: 28.45 (+0.04), HAR: 145.10 (-1.39), GOLD: 74.55 (-1.54), FB: 81.53 (-0.88), NCR: 28.88 (-1.01), AU: 10.65 (-0.47), IAG: 2.12 (-0.03), MCP: 0.99 (+0.15), BA: 148.40 (-1.47), AVL: 0.30 (+0.01), IWB: 118.66 (+0.17), NG: 3.58 (-0.04), NFX: 38.76 (+0.72), PXD: 174.10 (-1.06), OSN: 0.70 (-0.03), TXN: 54.73 (+0.01), FNV: 49.24 (-1.07), PAAS: 9.18 (-0.15), MCD: 98.74 (+1.74), RGLD: 62.30 (-1.76), MRO: 30.33 (-0.22), AUY: 3.83 (-0.10), NVS: 104.28 (-1.22), KMI: 44.34 (-0.23), DHI: 26.57 (+0.42), CCJ: 17.30 (+0.03), CLR: 51.35 (-1.25), GFI: 4.10 (-0.19), LVS: 55.25 (+0.13), REMX: 27.59 (+0.33), URZ: 1.25 (-0.04), SU: 33.06 (+0.08), T: 34.01 (-0.22), UEC: 2.31 (-0.09), ECA: 14.00 (-0.04), XLP: 49.19 (+0.01), GMO: 0.80 (-0.04), V: 67.48 (-0.24), EBAY: 59.20 (+0.31), EGO: 4.70 (-0.20), S: 5.27 (+0.03), BHP: 51.04 (+1.82), TRN: 28.70 (-4.66), QCOM: 68.24 (-0.10), ANGI: 6.16 (-0.24), URG: 1.04 (+0.01), GOOGL: 573.66 (+16.20), EMC: 26.50 (-0.09), TWC: 155.26 (+6.50), AGI: 6.71 (-0.11), XLF: 24.28 (-0.04), AAPL: 130.28 (+0.61), REE: 0.76 (-0.03), APC: 92.65 (-0.81), KO: 40.89 (-0.06), BAM: 55.58 (+0.03), AMZN: 445.10 (+55.11), ABT: 48.32 (-0.14), ABX: 12.52 (-0.12), NEM: 24.98 (+1.53), DB: 34.26 (+0.11), ASML: 107.16 (-1.53), XLV: 74.39 (-0.24), VSI: 42.98 (-0.15), BIDU: 216.90 (+4.62), ARRS: 35.76 (-1.54), LEU: 5.22 (+0.58), CMCSA: 59.64 (+0.41), SBGL: 8.64 (-0.72), GG: 19.01 (-0.51), BABA: 84.57 (+2.29)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Trinity Industries Inc. - TRN
Business Wire - Wed Apr 22, 6:24PM CDT
The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of Trinity Industries Inc. (NYSE:TRN) resulting from allegations that Trinity may have issued materially misleading business information to the investing public.
TRN: 28.70 (-4.66)

Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Trinity Industries, Inc.
PR Newswire - Wed Apr 22, 4:35PM CDT
Bernstein Liebhard LLP is investigating whether Trinity Industries, Inc. ("Trinity" or the "Company" (NYSE: TRN) issued materially false and misleading statements to investors in violation of the federal securities laws.
TRN: 28.70 (-4.66)

Why Trinity Industries Inc's Shares Crashed 10% Today
Travis Hoium, The Motley Fool - Motley Fool - Wed Apr 22, 4:33PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of industrial products company Trinity...
TRN: 28.70 (-4.66)

Trinity Industries Falls 9.46% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Apr 22, 4:24PM CDT
Trinity Industries (NYSE:TRN) traded in a range yesterday that spanned from a low of $32.59 to a high of $35.19. Yesterday, the shares fell 9.5%, which took the trading range below the 3-day low of $35.20 on volume of 8.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TRN: 28.70 (-4.66)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles